Glenmark to use Rs 296 crore loan for debt refinance, capex
The IFC has committed an unsecured loan of $40 million to the company.
Chennai: Pharma major Glenmark Pharmaceuticals Ltd will be utilising the $40 million loan from International Finance Corporation (IFC) to refinance existing debt and for capital expenditure.Glenmark is having a good presence in generics, over the counter and specialty drugs.The IFC has committed an unsecured loan of $40 million to the company.Queried about the deployment of the loan fund...
Chennai: Pharma major Glenmark Pharmaceuticals Ltd will be utilising the $40 million loan from International Finance Corporation (IFC) to refinance existing debt and for capital expenditure.
Glenmark is having a good presence in generics, over the counter and specialty drugs.
The IFC has committed an unsecured loan of $40 million to the company.
Queried about the deployment of the loan fund a company spokesperson told IANS: "The $40 mn loan will be utilized to refinance existing Foreign Currency Convertible Bonds (FCCBs) and capex funding."
The IFC in 2016 had invested in convertible debt of $75 million in Glenmark for expansion project.
Read also: Glenmark gets Rs 290 crore COVID credit line from IFC
According to the Glenmark spokesperson, IFC had subscribed to the company's FCCB for a principal of $75 million.
"The FCCB's have maturity in June 2022 and are not yet converted," the official said.
Read also: Glenmark secures CDSCO panel nod for manufacturing, marketing acne drug Tazarotene
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd